Use of somatostatin analogs in meningioma

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/31 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2705977

The present invention relates to the use of a Somatostatin (SRIF) analog which has a high binding affinity to human SSTR1,2,3,5, or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical composition for the treatment of meningioma.

L'invention concerne l'utilisation d'un analogue de la somatostatine (SRIF) qui a une haute affinité de liaison à un récepteur humain de la somatostatine SSTR1,2,3,5, ou un sel pharmaceutiquement acceptable de celui-ci, pour la préparation d'une composition pharmaceutique pour le traitement du méningiome.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of somatostatin analogs in meningioma does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of somatostatin analogs in meningioma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of somatostatin analogs in meningioma will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1793764

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.